Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

May 16, 2014

A Fresh Approach to Bone Marrow Transplant in Older Patients

Myeloconditioning offers a new alternative to age 55+ patients with blood cancers.

A Fresh Approach to Bone Marrow Transplant in Older Patients

Bone marrow transplant is the only potentially curative treatment option for older AML patients, but patients over the age of 55 are frequently ineligible for conventional care. [vetpathologist – Shutterstock]

Bone marrow transplants are currently a $13 billion market, 1 representing the fastest-growing hospital procedure in the United States They are the only potential cure for many blood cancers such as acute myeloid leukemia (AML) in older patients The procedure is technically called hematopoietic stem cell transplantation (HSCT) and can ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content